Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
63,300
+1,500 (2.43%)
Jun 2, 2026, 3:30 PM KST
Mezzion Pharma Market Cap
Mezzion Pharma has a market cap or net worth of 1.92 trillion as of June 3, 2026. Its market cap has increased by 68.72% in one year.
Market Cap
1.92T
Enterprise Value
1.92T
Revenue
7.97B
Ranking
n/a
PE Ratio
n/a
Stock Price
63,300.00
Market Cap Chart
Since January 20, 2012, Mezzion Pharma's market cap has increased from 240.02B to 1.92T, an increase of 701.52%. That is a compound annual growth rate of 15.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 1.92T | -29.68% |
| Dec 30, 2025 | 2.74T | 195.96% |
| Dec 30, 2024 | 924.37B | -19.89% |
| Dec 28, 2023 | 1.15T | 231.92% |
| Dec 29, 2022 | 347.65B | -82.01% |
| Dec 30, 2021 | 1.93T | 23.60% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 63.74T |
| Celltrion | 40.43T |
| ALTEOGEN | 19.58T |
| Samsung Epis Holdings | 12.01T |
| Hanmi Science | 2.24T |
| Celltrion Pharm | 2.09T |
| L&C BIO Co.,LTD | 1.84T |
| GC Biopharma | 1.57T |